- Home
- UTC Development
Universal Therapeutic Conjugate (UTC) Development Services
At Creative Biolabs , we specialize in preclinical development of innovative antibody-based conjugates to empower your research. Our comprehensive services include antibody-antibiotic conjugate (AAC), antibody-enzyme conjugate, antibody-biopolymer conjugate (ABC), antibody-immunostimulant conjugate, and antibody-oligonucleotide conjugate (AOC) development, alongside fragment-drug conjugate, bispecific adc, and antibody-based probe services. Leveraging advanced technologies, our experienced team offers tailored solutions for target identification, conjugation strategy design, synthesis, and rigorous characterization. Whether optimizing payload-linker systems or ensuring specificity and safety in preclinical models, we deliver end-to-end support to accelerate your therapeutic or diagnostic projects
Antibody-Antibiotic Conjugate (AAC) Development Services: Tailored preclinical solutions for designing and optimizing AACs to enable targeted antibiotic delivery, enhancing efficacy and reducing systemic toxicity.
Antibody-Enzyme Conjugate Development Services:Specialized in creating antibody-enzyme conjugates for cancer therapy, supporting preclinical design for prodrug activation and diagnostic applications.
Antibody-Biopolymer Conjugate (ABC) Development Service: Preclinical development of ABCs using biopolymer carriers to improve conjugate stability, pharmacokinetics, and targeted delivery.
Antibody-Immunostimulant Conjugate Development Services: Preclinical expertise in generating conjugates that deliver immunostimulants to specific targets, enhancing anti-tumor immune responses.
Antibody-Oligonucleotide Conjugate (AOC) Development Services: End-to-end preclinical support for AOCs, enabling efficient delivery of oligonucleotides to modulate gene expression with improved cellular uptake.
Fragment-Drug Conjugate Development Services: Preclinical development of fragment-drug conjugates to leverage small molecule fragments for enhanced target engagement and therapeutic precision.
Bispecific ADC Development Services: Custom preclinical design of antibody-based probes for imaging and diagnostics, enabling accurate disease localization and biomarker detection.
Antibody-based Probe Development Services: Preclinical solutions for bispecific antibody-drug conjugates, facilitating dual-target recognition to enhance specificity and therapeutic efficacy.
Unlock the potential of your preclinical research with our cutting-edge conjugate development services. Our experts are ready to collaborate on your unique needs, providing scientific excellence and customized strategies. Contact us today to discuss how Creative Biolabs can drive your project forward efficiently and effectively.
For Research Use Only. NOT FOR CLINICAL USE.
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
